Bluezone Insurance launches dedicated Type 2 Diabetes cover

First life insurance policy goes live

John Brazier
clock • 2 min read

Bluezone Insurance has gone live with its first life insurance proposition, designed specifically for consumers with Type 2 diabetes.

The policy is aimed at offering cover to a segment of customers that have previously been unable to secure life insurance due to the condition, as well as "removing lengthy form filling and required medical appointments previously needed to secure a similar policy." Bluezone stated that the launch comes at "a critical time" as there are more than four million people in the UK that have been diagnosed with Type 2 diabetes, with a further one million people unaware that they are living with a chronic illness. Speaking to COVER last year, Dr Karan Mehta, co-founder and chief executive of...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

LifeSearch partners with Yorkshire Building Society

LifeSearch partners with Yorkshire Building Society

No commission to be made for referrals

Jaskeet Briah
clock 13 January 2025 • 2 min read
Claims and Underwriting: Claiming after an induced coma

Claims and Underwriting: Claiming after an induced coma

"Chasing the wrong definition"

Jaskeet Briah
clock 09 January 2025 • 6 min read
Third of young adults turn to influencers for financial education

Third of young adults turn to influencers for financial education

Young adults "unprepared for common financial situations”

Jaskeet Briah
clock 08 January 2025 • 2 min read